At low doses, JDA induces tumor cell senescence by inactivating the c-Myc-AP4 pathway, while high doses of JDA upregulate the expression levels of LC3B, cleaved PARP, and cleaved caspase-3 in GC cells. The gene discussed is CASP3; the disease is gastric cancer.